Matches in Wikidata for { <http://www.wikidata.org/entity/Q85706825> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q85706825 description "artículu científicu espublizáu n'agostu de 2015" @default.
- Q85706825 description "scientific article published on 01 August 2015" @default.
- Q85706825 description "wetenschappelijk artikel" @default.
- Q85706825 description "наукова стаття, опублікована в серпні 2015" @default.
- Q85706825 name "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 name "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 type Item @default.
- Q85706825 label "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 label "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 prefLabel "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 prefLabel "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 P1433 Q85706825-E3B3D602-52A9-4D1E-9514-8534F01EED2D @default.
- Q85706825 P1476 Q85706825-93CB7ED1-DF7D-48D1-B83E-065038B78FC8 @default.
- Q85706825 P2093 Q85706825-17B3160D-29C5-44F8-B881-BB4F3C709A1D @default.
- Q85706825 P2093 Q85706825-8307EE63-C1F3-43F6-8864-C6FDE41879DF @default.
- Q85706825 P2093 Q85706825-87923D75-14FF-4D82-BB1A-5A531AE409E4 @default.
- Q85706825 P2093 Q85706825-E1C33C7A-AAC2-4573-B904-76734FF255B6 @default.
- Q85706825 P304 Q85706825-6D441DA1-56A7-44D9-A42A-227B8BEE42B0 @default.
- Q85706825 P31 Q85706825-1FEF68C6-D0B6-448D-866F-A502F6DB7292 @default.
- Q85706825 P356 Q85706825-05A7C293-C635-4082-9140-F51A623D70A2 @default.
- Q85706825 P407 Q85706825-999F3C98-49DC-4894-BB5D-8E707ACD95E0 @default.
- Q85706825 P433 Q85706825-37331889-AC2C-4D69-801C-018B5AED2485 @default.
- Q85706825 P478 Q85706825-633D2390-0BE6-452C-9EA8-BEC3D4941C29 @default.
- Q85706825 P50 Q85706825-00F394E8-3A0E-4E81-95FC-CE21AAAE74AD @default.
- Q85706825 P50 Q85706825-1BCF0642-964C-46CD-AFA6-A221D279CF82 @default.
- Q85706825 P50 Q85706825-CD077245-E423-4213-A1D6-B7CBE691623C @default.
- Q85706825 P577 Q85706825-CA8A77FE-8562-4A06-9493-863A80B898C6 @default.
- Q85706825 P698 Q85706825-47973B17-35AC-4C58-A6C6-1A515D06B0C0 @default.
- Q85706825 P356 L15-5118 @default.
- Q85706825 P698 26237757 @default.
- Q85706825 P1433 Q564416 @default.
- Q85706825 P1476 "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia" @default.
- Q85706825 P2093 "Anna Bettina Haidich" @default.
- Q85706825 P2093 "Eleni Athanasiadou" @default.
- Q85706825 P2093 "Evangelos C Rizos" @default.
- Q85706825 P2093 "Maria Mainou" @default.
- Q85706825 P304 "241" @default.
- Q85706825 P31 Q13442814 @default.
- Q85706825 P356 "10.7326/L15-5118" @default.
- Q85706825 P407 Q1860 @default.
- Q85706825 P433 "3" @default.
- Q85706825 P478 "163" @default.
- Q85706825 P50 Q51454116 @default.
- Q85706825 P50 Q58364475 @default.
- Q85706825 P50 Q58933953 @default.
- Q85706825 P577 "2015-08-01T00:00:00Z" @default.
- Q85706825 P698 "26237757" @default.